Koyfin Home > Directory > Health Care > Acorda Therapeutics > Cash from Investing Activities

Acorda Therapeutics Cash from Investing Activities Chart (ACOR)

Acorda Therapeutics annual/quarterly Cash from Investing Activities from 2010 to 2020.
  • Acorda Therapeutics Cash from Investing Activities for the quarter ending June 06, 2020 was $23m a 114.15% increase of 26m year over year
  • Acorda Therapeutics Cash from Investing Activities for the last 12 months ending June 06, 2020 was $87m a 182.07% increase of 158m year over year
  • Acorda Therapeutics Annual Cash from Investing Activities for 2019 was $-1m a -34,922.77% increase of 176m from 2018
  • Acorda Therapeutics Annual Cash from Investing Activities for 2018 was $-177m a 93.94% decrease of -166m from 2017
  • Acorda Therapeutics Annual Cash from Investing Activities for 2017 was $-11m a -588.75% increase of 63m from 2016
Other Cash Flow Metrics:
  • Acorda Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $78m a 23.00% increase of 18m year over year
  • Acorda Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $60m a 1.90% increase of 1m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Cash from Investing Activities Data

06/2020$23m
03/2020$11m
12/2019$56m
09/2019$-3m
06/2019$-35m
03/2019$-18m
12/2018$-15m
09/2018$-3m
06/2018$-48m
03/2018$-112m

Annual ACOR Cash from Investing Activities Data

2019$-1m
2018$-177m
2017$-11m
2016$-74m
2015$-85m
2014$-294m
2013$-45m
2012$-71m
2011$-45m
2010$5m